Plasma Indoleamine 2,3-Dioxygenase and Arginase Type I May Contribute to Decreased Blood T-Cell Count in Hemodialysis Patients

REFERENCES

• Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semi Dialysis. 2007;20:440–451.
   PubMed Web of Science ®Google Scholar
• Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113:25–27.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Tsiaga P, Antoniadi G, . The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis. 2005;46:706–712.
   PubMedGoogle Scholar
• Kreft B, Klouche M, Kreft R, Kirchner H, Sack K. Low efficiency of active immunization against diphtheria in chronic hemodialysis patients. Kidney Int. 1997;52:212–216.
   PubMedGoogle Scholar
• Friedman EA, Beyer MM, Hirsch SR, Schiffman G. Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes. JAMA. 1980;244:2310–2311.
   PubMed Web of Science ®Google Scholar
• King NJ, Thomas SR. Molecules in focus: Indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol. 2007;39:2167–2172.
   PubMed Web of Science ®Google Scholar
• Mulley WR, Nikolic-Paterson DJ. Indoleamine 2,3-dioxygenase in transplantation. Nephrology (Carlton). 2008;13:204–211.
   PubMed Web of Science ®Google Scholar
• Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: Focus on hematology. Blood. 2009;113:2394–2401.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Ido expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762–774.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Creating immune privilege: Active local suppression that benefits friends, but protects foes. Nat Rev Immunol. 2008;8:74–80.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Vacca C, . T cell apoptosis by tryptophan catabolism. Cell Death Differ. 2002;9:1069–1077.
   PubMed Web of Science ®Google Scholar
• Darcy CJ, Davis JS, Woodberry T, . An observational cohort study of the kynurenine to tryptophan ratio in sepsis: Association with impaired immune and microvascular function. PLoS One. 2011;6:e21185.
   PubMedGoogle Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–174.
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002;277:21123–21129.
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood. 2007;109:1568–1573.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Kartsios C, Yiannaki E, . Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am J Nephrol. 2008;28:152–157.
   PubMed Web of Science ®Google Scholar
• Moline-Velazquez V, Cuervo H, Vila-Del Sol V, Ortega MC, Clemente D, de Castro F. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol. 2011;21:678–691.
   PubMedGoogle Scholar
• Liu YY, Sun LC, Wei JJ, . Tumor cell-released TLR4 ligands stimulate Gr-1+CD11b+F4/80+ cells to induce apoptosis of activated T cells. J Immunol. 2010;185:2773–2782.
   PubMedGoogle Scholar
• Popovic PJ, Zeh III HJ, Ochoa JB. Arginine and immunity. J Nutr. 2007;137:1681S–1686S.
   PubMed Web of Science ®Google Scholar
• Ankersmit HJ, Deicher R, Moser B, . Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing hemodialysis. Clin Exp Immunol. 2001;125:142–148.
   PubMedGoogle Scholar
• Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. JASN. 2002;13:204–212.
   Google Scholar
• Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde KH. Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect. Kidney Int. 1986;29:1209–1214.
   PubMedGoogle Scholar
• Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol. 1996;114:107–132.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Okuda K, Endo N, . Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology. 1995;109:1295–1300.
   PubMed Web of Science ®Google Scholar
• Schefold JC, Zeden JP, Fotopoulou C, . Increased indoleamine 2,3-dioxygenase (ido) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: A possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant. 2009;24:1901–1908.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I, Galaktidou G. Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. Vaccine. 2011;29:2242–2247.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Antoniadi G, Liakopoulos V, Stefanidis I, Galaktidou G. Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease. Ren Fail. 2012;34:68–72.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Brzosko S, Mysliwiec M, Pawlak D. Kynurenine, quinolinic acid—The new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis. 2009;204:561–566.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I, Galaktidou G. Arginase type I as a marker of coronary heart disease in hemodialysis patients. Int Urol Nephrol. 2011;43:1187–1194.
   PubMedGoogle Scholar
• Asano K, Sachs MS. Translation factor control of ribosome conformation during start codon selection. Genes Dev. 2007;21:1280–1287.
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Baban B, . GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22:633–642.
   PubMed Web of Science ®Google Scholar
• Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5:641–654.
   PubMed Web of Science ®Google Scholar